Medicare Enrolled
Dr. Edit Tolnai, M.D.
Hematology · Jupiter, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tolnai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tolnai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tolnai
Dr. Edit Tolnai is a hematology specialist in Jupiter, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Tolnai performed 24,003 Medicare services across 2,749 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tolnai received a total of $16,969 from 82 pharmaceutical and/or device companies across 1021 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tolnai is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ 24,003 Medicare services
$16,969 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 88991 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗24,003
Medicare services
Bottom 30% in FL for hematology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
2,749
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,200 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
5,700 | $0 | $5 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
5,000 | $6 | $35 |
| Denosumab injection (Prolia/Xgeva) | 3,120 | $19 | $45 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,800 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,303 | $8 | $14 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,207 | $8 | $34 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
904 | $96 | $334 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
881 | $10 | $46 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
818 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 470 | $1 | $59 |
| Direct bilirubin level test A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver. |
464 | $5 | $22 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
348 | $6 | $26 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
237 | $11 | $75 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
196 | $7 | $29 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
186 | $102 | $477 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
175 | $22 | $107 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
146 | $19 | $83 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
99 | $139 | $447 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
76 | $69 | $226 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
74 | $16 | $73 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
73 | $9 | $39 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
68 | $1,162 | $3,581 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 68 | $401 | $982 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 67 | $20 | $89 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
65 | $58 | $238 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 60 | $137 | $685 |
| New patient office visit, complex (60-74 min) | 59 | $176 | $638 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
55 | $26 | $113 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
49 | $50 | $236 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
47 | $52 | $231 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
40 | $38 | $649 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
32 | $11 | $74 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
24 | $132 | $502 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
22 | $67 | $426 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
20 | $4 | $15 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
14 | $142 | $642 |
| Stool test for blood A laboratory test that checks a stool sample for hidden blood using a chemical reaction. This test helps detect bleeding in the digestive tract. |
13 | $4 | $14 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
12 | $47 | $807 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
11 | $133 | $812 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.9% high complexity
72.7% medium
25.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,969
Total received (2018-2024)
Avg $2,424/year across 7 years
Top 28% in FL for hematology
82
Companies
1,021
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,392 (90.7%)
Other
Charitable contributions, space rental, and other categories
$1,101 (6.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$477 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$168
2023
$3,066
2022
$2,834
2021
$3,265
2020
$1,825
2019
$2,964
2018
$2,848
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,660
AstraZeneca Pharmaceuticals LP
$1,283
PFIZER INC.
$1,016
Janssen Biotech, Inc.
$921
Lilly USA, LLC
$834
Amgen Inc.
$796
Incyte Corporation
$778
E.R. Squibb & Sons, L.L.C.
$734
Celgene Corporation
$637
GENZYME CORPORATION
$572
Astellas Pharma US Inc
$558
Genentech USA, Inc.
$556
Merck Sharp & Dohme LLC
$426
Merck Sharp & Dohme Corporation
$391
Daiichi Sankyo Inc.
$373
GlaxoSmithKline, LLC.
$338
Seattle Genetics, Inc.
$287
Eisai Inc.
$285
Seagen Inc.
$246
Takeda Pharmaceuticals U.S.A., Inc.
$240
Pacira Pharmaceuticals Incorporated
$232
Bayer HealthCare Pharmaceuticals Inc.
$183
Taiho Oncology, Inc.
$175
Boehringer Ingelheim Pharmaceuticals, Inc.
$175
EISAI INC.
$157
Exelixis Inc.
$155
Alexion Pharmaceuticals, Inc.
$142
Ipsen Biopharmaceuticals, Inc
$133
AbbVie Inc.
$119
Regeneron Healthcare Solutions, Inc.
$113
Puma Biotechnology, Inc.
$110
Medtronic USA, Inc.
$108
Adaptive Biotechnologies Corporation
$106
Karyopharm Therapeutics Inc.
$100
PUMA BIOTECHNOLOGY, INC.
$92
AbbVie, Inc.
$89
ARRAY BIOPHARMA INC
$88
Pharmacyclics LLC, An AbbVie Company
$87
Kyowa Kirin, Inc.
$83
ABBVIE INC.
$80
Kite Pharma, Inc.
$79
MEDIVATION FIELD SOLUTIONS LLC
$76
Pharmacosmos Therapeutics Inc.
$74
Dova Pharmaceuticals
$70
TESARO, Inc.
$67
Helsinn Therapeutics (U.S.), Inc.
$64
JAZZ PHARMACEUTICALS INC.
$62
Fennec Pharmaceuticals, Inc.
$60
SOBI, INC
$57
EMD Serono, Inc.
$56
Advanced Accelerator Applications
$48
BeiGene USA, Inc.
$43
Clovis Oncology, Inc.
$43
Gilead Sciences, Inc.
$43
CTI BioPharma Corp.
$39
Foundation Medicine, Inc.
$37
Deciphera Pharmaceuticals Inc.
$37
Bayer Healthcare Pharmaceuticals Inc.
$36
Pharmacyclics LLC, an AbbVie Company
$35
Sobi, Inc
$34
AVEO Pharmaceuticals, Inc.
$34
Stemline Therapeutics Inc.
$33
MorphoSys, US Inc.
$32
Octapharma USA, Inc.
$29
Global Blood Therapeutics, Inc.
$25
Legend Biotech USA Inc.
$24
SERVIER PHARMACEUTICALS LLC
$24
PharmaEssentia USA Corporation
$23
Myriad Genetic Laboratories, Inc.
$20
Mylan Institutional Inc.
$19
Rigel Pharmaceuticals, Inc.
$19
Otsuka America Pharmaceutical, Inc.
$18
Array BioPharma Inc.
$17
Ethicon US, LLC
$17
Fortovia Therapeutics, Inc.
$16
Organon LLC
$16
TG THERAPEUTICS, INC.
$16
Heron Therapeutics, Inc.
$15
Mirati Therapeutics, Inc.
$15
Sun Pharmaceutical Industries Inc.
$13
Agios Pharmaceuticals, Inc.
$13
NanoString Technologies, Inc.
$11
Top 3 companies account for 23.3% of total payments
Associated products mentioned in payments ›
6 · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CERTUS 140 MICROWAVE ABLATION SYSTEM · CHANTIX · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ENHERTU · ENJAYMO · ERLEADA · EXPAREL · Enhertu · FOTIVDA · FOUNDATIONONE · GAZYVA · GILOTRIF · Gazyva · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUMOXITI · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION · OXBRYTA · Ogivri · Orserdu · PADCEV · PEMAZYRE · PIQRAY · POTELIGEO · PROMACTA · PROSIGNA ASSAY · Pedmark · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · Revlimid · Rubraca · SANCUSO · SARCLISA · SHINGRIX · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vitrakvi · Vonjo · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · ZEJULA · ZEPZELCA · ZYTIGA · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $71 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
11
Per 100K population
0.7
County median income
$81,115
Nearest hospital
JUPITER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Tolnai is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Tolnai experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Dr. Tolnai performed 5,700 anti-nausea injection (fosaprepitant) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tolnai receive payments from pharmaceutical companies?
Yes. Dr. Tolnai received a total of $16,969 from 82 companies across 1,021 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tolnai's costs compare to other hematologists in Jupiter?
Dr. Tolnai's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tolnai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Jupiter
Browse hematologists in Jupiter ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology